鞘氨醇激酶与1-磷酸鞘氨醇：自身免疫性疾病和炎症性疾病中的调节因子
Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.
作者信息
Snider Ashley J
机构信息
Northport Veterans Affairs Medical Center, Northport, NY 11768, USA and Department of Medicine, Stony Brook University, 100 Nicolls Road, Health Sciences Center L15-023, Stony Brook, NY 11794, USA.
出版信息
Int J Clin Rheumtol. 2013 Aug 1;8(4). doi: 10.2217/ijr.13.40.
Abstract
Sphingolipids and their metabolizing enzymes are beginning to be recognized as critical mediators in biological processes, specifically in inflammation and autoimmunity. Sphingosine kinases (SKs) and their lipid product sphingosine-1-phosphate (S1P) play essential roles in inflammatory signaling processes, as well as disease development and progression. SKs can be activated by numerous growth factors and cytokines, including TNF-α and IL-1β, leading to the generation of S1P. S1P exerts its biological effects on intracellular and extracellular targets, such as S1P receptors. In addition to roles in inflammatory signaling pathways SKs, S1P and S1P receptors have been implicated in immune cell function and trafficking, specifically in lymphocytes. This review will discuss the contribution of the bioactive sphingolipid S1P, its generating enzyme SK, and its cell surface receptors in the inflammatory and autoimmune diseases systemic lupus erythematosus, arthritis and inflammatory bowel disease.
摘要
鞘脂及其代谢酶开始被认为是生物过程中的关键介质，特别是在炎症和自身免疫方面。鞘氨醇激酶（SKs）及其脂质产物鞘氨醇-1-磷酸（S1P）在炎症信号传导过程以及疾病的发生和发展中起着重要作用。SKs可被多种生长因子和细胞因子激活，包括TNF-α和IL-1β，从而导致S1P的生成。S1P对细胞内和细胞外靶点发挥其生物学作用，如S1P受体。除了在炎症信号通路中的作用外，SKs、S1P和S1P受体还与免疫细胞功能和运输有关，特别是在淋巴细胞中。本综述将讨论生物活性鞘脂S1P、其生成酶SK及其细胞表面受体在炎症和自身免疫性疾病系统性红斑狼疮、关节炎和炎症性肠病中的作用。
相似文献
1
Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.鞘氨醇激酶与1-磷酸鞘氨醇：自身免疫性疾病和炎症性疾病中的调节因子
Int J Clin Rheumtol. 2013 Aug 1;8(4). doi: 10.2217/ijr.13.40.
2
Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.鞘氨醇激酶：在炎症中调节生物活性鞘脂介质中的作用。
Biochimie. 2010 Jun;92(6):707-15. doi: 10.1016/j.biochi.2010.02.008. Epub 2010 Feb 13.
3
Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.鞘脂类作为炎症的介质及炎症性肠病的新型治疗靶点。
Adv Protein Chem Struct Biol. 2020;120:123-158. doi: 10.1016/bs.apcsb.2019.11.003. Epub 2020 Jan 8.
4
Role of sphingosine-1-phosphate mediated signalling in systemic lupus erythematosus.1-磷酸鞘氨醇介导的信号传导在系统性红斑狼疮中的作用
Prostaglandins Other Lipid Mediat. 2021 Oct;156:106584. doi: 10.1016/j.prostaglandins.2021.106584. Epub 2021 Aug 2.
5
Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.狼疮肾炎小鼠模型中鞘氨醇激酶 2 的抑制作用。
PLoS One. 2013;8(1):e53521. doi: 10.1371/journal.pone.0053521. Epub 2013 Jan 3.
6
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.鞘氨醇激酶和鞘氨醇-1-磷酸受体信号通路在炎症性胃肠道疾病和癌症中的作用：一个新的治疗靶点。
Pharmacol Ther. 2020 Mar;207:107464. doi: 10.1016/j.pharmthera.2019.107464. Epub 2019 Dec 18.
7
Role of sphingosine kinase localization in sphingolipid signaling.鞘氨醇激酶定位在鞘脂信号传导中的作用。
World J Biol Chem. 2010 Dec 26;1(12):362-8. doi: 10.4331/wjbc.v1.i12.362.
8
S1P/S1PR signaling pathway advancements in autoimmune diseases.S1P/S1PR 信号通路在自身免疫性疾病中的研究进展。
Biomol Biomed. 2023 Nov 3;23(6):922-935. doi: 10.17305/bb.2023.9082.
9
Roles of sphingosine-1-phosphate signaling in cancer.鞘氨醇-1-磷酸信号传导在癌症中的作用。
Cancer Cell Int. 2019 Nov 14;19:295. doi: 10.1186/s12935-019-1014-8. eCollection 2019.
10
The role of sphingosine 1-phosphate metabolism in bone and joint pathologies and ectopic calcification.鞘氨醇-1-磷酸代谢在骨骼关节疾病和异位钙化中的作用。
Bone. 2020 Jan;130:115087. doi: 10.1016/j.bone.2019.115087. Epub 2019 Oct 21.
引用本文的文献
1
Serum Metabolomics Study to Screen Potential Biomarkers of Lung Cancer Risk in High Natural Background Radiation Areas of Thailand: A Pilot Study.泰国高天然本底辐射地区肺癌风险潜在生物标志物筛查的血清代谢组学研究：一项初步研究。
Cancers (Basel). 2024 Dec 15;16(24):4182. doi: 10.3390/cancers16244182.
2
Is Sphingosine Kinase 1 Associated with Hematological Malignancy? A Systematic Review and Meta-Analysis.丝氨酸棕榈酰转移酶 1 与血液系统恶性肿瘤有关吗？系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2605-2613. doi: 10.31557/APJCP.2024.25.8.2605.
3
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells.奥帕加尼布下调N-Myc表达并抑制神经母细胞瘤细胞的体外和体内生长。
Cancers (Basel). 2024 May 5;16(9):1779. doi: 10.3390/cancers16091779.
4
Apolipoprotein M gene polymorphisms in childhood-onset type 1 diabetes in southern Brazil.巴西南部儿童期发病的1型糖尿病中的载脂蛋白M基因多态性
Int J Biochem Mol Biol. 2023 Aug 15;14(4):51-61. eCollection 2023.
5
Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Behçet's disease.血浆和 PBMCs 的整合代谢组学鉴定出 Behçet's 病的独特代谢特征。
Arthritis Res Ther. 2023 Jan 7;25(1):5. doi: 10.1186/s13075-022-02986-5.
6
Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.脂肪和蛋白质对抗先天和适应性免疫系统的触发因素，引发帕金森病的神经炎症。
Int J Mol Sci. 2022 Jan 19;23(3):1089. doi: 10.3390/ijms23031089.
7
The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways.鞘脂信号通路在免疫调节中的作用：鞘氨醇激酶 1 和鞘氨醇激酶 2 依赖性通路的抗炎作用存在二分法。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211053274. doi: 10.1177/20587384211053274.
8
HDL and persistent inflammation immunosuppression and catabolism syndrome.高密度脂蛋白与持续炎症免疫抑制和分解代谢综合征。
Curr Opin Lipidol. 2021 Oct 1;32(5):315-322. doi: 10.1097/MOL.0000000000000782.
9
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.鞘脂类物质与系统性红斑狼疮的诊断、预后和器官损伤。
Front Immunol. 2020 Sep 25;11:586737. doi: 10.3389/fimmu.2020.586737. eCollection 2020.
10
The S1P-S1PR Axis in Neurological Disorders-Insights into Current and Future Therapeutic Perspectives.鞘氨醇-1-磷酸受体轴在神经疾病中的作用：对当前和未来治疗策略的深入了解
Cells. 2020 Jun 22;9(6):1515. doi: 10.3390/cells9061515.
本文引用的文献
1
Molecular basis of sphingosine kinase 1 substrate recognition and catalysis.鞘氨醇激酶 1 底物识别和催化的分子基础。
Structure. 2013 May 7;21(5):798-809. doi: 10.1016/j.str.2013.02.025. Epub 2013 Apr 18.
2
Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study.在首例人体研究中，对 S1P1 受体调节剂 ponesimod 的药代动力学和药效学研究。
Br J Clin Pharmacol. 2013 Dec;76(6):888-96. doi: 10.1111/bcp.12129.
3
Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis.狼疮肾炎小鼠模型中鞘氨醇激酶 2 的抑制作用。
PLoS One. 2013;8(1):e53521. doi: 10.1371/journal.pone.0053521. Epub 2013 Jan 3.
4
S1P₁ localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.S1P₁ 在溃疡性结肠炎中定位于结肠血管，并维持血管完整性。
J Lipid Res. 2013 Mar;54(3):843-851. doi: 10.1194/jlr.M034108. Epub 2013 Jan 7.
5
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.鞘氨醇-1-磷酸将持续的 STAT3 激活、慢性肠道炎症和结肠炎相关癌症的发展联系起来。
Cancer Cell. 2013 Jan 14;23(1):107-20. doi: 10.1016/j.ccr.2012.11.013. Epub 2012 Dec 27.
6
Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis.鞘氨醇激酶 2 缺乏对 TNF-α诱导的炎症性关节炎发展的影响。
Rheumatol Int. 2013 Oct;33(10):2677-81. doi: 10.1007/s00296-012-2493-2. Epub 2012 Aug 3.
7
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.抑制鞘氨醇激酶 2 会升高循环鞘氨醇 1-磷酸。
Biochem J. 2012 Oct 1;447(1):149-57. doi: 10.1042/BJ20120609.
8
Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus.幼年特发性关节炎患者血清神经鞘氨醇-1-磷酸浓度升高。
J Clin Immunol. 2012 Oct;32(5):1019-25. doi: 10.1007/s10875-012-9710-3. Epub 2012 May 31.
9
The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.鞘氨醇-1-磷酸类似物 FTY720 损害黏膜免疫和肠道病原体柠檬酸杆菌的清除。
Infect Immun. 2012 Aug;80(8):2712-23. doi: 10.1128/IAI.06319-11. Epub 2012 May 21.
10
Immune regulation by sphingosine 1-phosphate and its receptors.鞘氨醇 1-磷酸及其受体的免疫调节作用。
Arch Immunol Ther Exp (Warsz). 2012 Feb;60(1):3-12. doi: 10.1007/s00005-011-0159-5. Epub 2011 Dec 8.
Zotero 插件